Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
43
NMRA Quote, Financials, Valuation and Earnings
Last price:
$2.29
Seasonality move
:
-54.68%
Day range:
$2.05 - $2.54
52-week range:
$0.61 - $3.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.90x
Volume:
13.5M
Avg. volume:
1.7M
1-year change:
-11.24%
Market cap:
$382.6M
Revenue:
--
EPS (TTM):
-$1.46
Earnings Data
Next earnings date for NMRA
Mar 02
2026
Most recent earnings per share
-$0.35
Missed by $0.02
(Nov 6/2025)
Consensus Estimate
-$0.34
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NMRA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | -- | -- | -- | -$0.32 | -- |
| 03/02/2026 | Q4 | -- | -- | -- | -$0.33 | -- |
| 11/06/2025 | Q3 | -- | -- | -$0.35 | -$0.34 | -$0.02 |
| 08/06/2025 | Q2 | -- | -- | -$0.33 | -$0.37 | $0.04 |
| 05/12/2025 | Q1 | -- | -- | -$0.42 | -$0.38 | -$0.04 |
| 03/03/2025 | Q4 | -- | -- | -$0.37 | -$0.44 | $0.08 |
| 11/12/2024 | Q3 | -- | -- | -$0.45 | -$0.38 | -$0.07 |
| 08/06/2024 | Q2 | -- | -- | -$0.37 | -$0.36 | -$0.01 |
| 05/07/2024 | Q1 | -- | -- | -$0.34 | -$0.32 | -$0.02 |
| 03/07/2024 | Q4 | -- | -- | -$0.68 | -$0.60 | -$0.08 |
| 11/01/2023 | Q3 | -- | -- | -$0.35 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.25 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.23 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.19 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.19 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.20 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.28 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.18 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$1.17 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.11 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.10 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.13 | -- | -- |
Neumora Therapeutics, Inc. Earnings Questions
-
How Much did Neumora Therapeutics, Inc. Generate in Revenue Last Quarter?
Neumora Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Neumora Therapeutics, Inc. Beat Earnings Last Quarter?
Neumora Therapeutics, Inc. announced earnings per share of -$0.35 which represents a miss of analyst forecast a -$0.34 per share.
-
Is Neumora Therapeutics, Inc. Profitable?
Neumora Therapeutics, Inc. reported -$23K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Neumora Therapeutics, Inc. EPS Next Year?
Neumora Therapeutics, Inc.'s earnings are forecast to decrease from -$1.53 per share to -$1.42 per share next year representing a decrease of -6.48%.
-
When is Neumora Therapeutics, Inc.'s Earnings Date?
Neumora Therapeutics, Inc.'s next earnings date is March 2, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
69
RGC alert for Jan 8
Regencell Bioscience Holdings Ltd. [RGC] is up 58.95% over the past day.
Buy
69
WDC alert for Jan 8
Western Digital Corp. [WDC] is down 8.88% over the past day.
Sell
38
CRNX alert for Jan 8
Crinetics Pharmaceuticals, Inc. [CRNX] is up 16.08% over the past day.
